Naz Rahman
Stock Analyst at Maxim Group
(0.09)
# 4,407
Out of 4,468 analysts
450
Total ratings
37.8%
Success rate
-7.5%
Average return
Main Sectors:
Stocks Rated by Naz Rahman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PALI Palisade Bio | Reiterated: Buy | $8 | $2.10 | +281.86% | 31 | Jun 29, 2026 | |
| VANI Vivani Medical | Reiterated: Buy | $4 | $1.27 | +216.21% | 25 | Jun 26, 2026 | |
| VKTX Viking Therapeutics | Reiterated: Buy | $70 | $36.89 | +89.75% | 37 | Jun 25, 2026 | |
| QNRX Quoin Pharmaceuticals | Reiterated: Buy | $40 → $16 | $4.71 | +239.70% | 33 | Jun 24, 2026 | |
| SLXN Silexion Therapeutics | Reiterated: Buy | $60 → $6 | $2.65 | +126.84% | 23 | Jun 24, 2026 | |
| NVCT Nuvectis Pharma | Rated: Buy | $17 → $30 | $19.98 | +50.15% | 13 | Jun 23, 2026 | |
| SCNX Scienture Holdings | Reiterated: Buy | $1.5 | $0.3413 | +339.50% | 2 | Jun 16, 2026 | |
| GLMD Galmed Pharmaceuticals | Maintained: Hold | n/a | $0.5817 | - | 13 | Jun 10, 2026 | |
| ACOG Alpha Cognition | Reiterated: Buy | $12 | $7.83 | +53.35% | 2 | Jun 10, 2026 | |
| KZIA Kazia Therapeutics | Rated: Buy | $20 → $30 | $13.52 | +121.89% | 13 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $5.41 | +47.87% | 27 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $575 | $522.74 | +10.00% | 33 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €16.00 | $4.28 | +273.83% | 6 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $0.56 | +257.14% | 33 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $1.08 | +179.07% | 13 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7 | $2.15 | +225.58% | 20 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $6.06 | +230.31% | 33 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $1.5 | $0.42 | +257.14% | 1 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $2.16 | - | 15 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.713 | - | 24 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.00511 | n/a | 11 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.36 | n/a | 21 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.00001 | n/a | 11 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $6.02 | n/a | 6 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $4.53 | n/a | 3 | Jan 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $8.91 | n/a | 1 | Aug 12, 2021 |
Palisade Bio
Jun 29, 2026
Reiterated: Buy
Price Target: $8
Current: $2.10
Upside: +281.86%
Vivani Medical
Jun 26, 2026
Reiterated: Buy
Price Target: $4
Current: $1.27
Upside: +216.21%
Viking Therapeutics
Jun 25, 2026
Reiterated: Buy
Price Target: $70
Current: $36.89
Upside: +89.75%
Quoin Pharmaceuticals
Jun 24, 2026
Reiterated: Buy
Price Target: $40 → $16
Current: $4.71
Upside: +239.70%
Silexion Therapeutics
Jun 24, 2026
Reiterated: Buy
Price Target: $60 → $6
Current: $2.65
Upside: +126.84%
Nuvectis Pharma
Jun 23, 2026
Rated: Buy
Price Target: $17 → $30
Current: $19.98
Upside: +50.15%
Scienture Holdings
Jun 16, 2026
Reiterated: Buy
Price Target: $1.5
Current: $0.3413
Upside: +339.50%
Galmed Pharmaceuticals
Jun 10, 2026
Maintained: Hold
Price Target: n/a
Current: $0.5817
Upside: -
Alpha Cognition
Jun 10, 2026
Reiterated: Buy
Price Target: $12
Current: $7.83
Upside: +53.35%
Kazia Therapeutics
Jun 4, 2026
Rated: Buy
Price Target: $20 → $30
Current: $13.52
Upside: +121.89%
Jun 3, 2026
Reiterated: Buy
Price Target: $8
Current: $5.41
Upside: +47.87%
Jun 2, 2026
Reiterated: Buy
Price Target: $575
Current: $522.74
Upside: +10.00%
May 22, 2026
Reiterated: Buy
Price Target: €16.00
Current: $4.28
Upside: +273.83%
May 19, 2026
Reiterated: Buy
Price Target: $2
Current: $0.56
Upside: +257.14%
May 15, 2026
Reiterated: Buy
Price Target: $3
Current: $1.08
Upside: +179.07%
May 15, 2026
Rated: Buy
Price Target: $7
Current: $2.15
Upside: +225.58%
May 15, 2026
Reiterated: Buy
Price Target: $20
Current: $6.06
Upside: +230.31%
Apr 20, 2026
Initiated Coverage: Buy
Price Target: $1.5
Current: $0.42
Upside: +257.14%
Nov 19, 2025
Maintained: Hold
Price Target: n/a
Current: $2.16
Upside: -
Aug 7, 2025
Maintained: Hold
Price Target: n/a
Current: $0.713
Upside: -
Dec 18, 2024
Maintained: Buy
Price Target: n/a
Current: $0.00511
Upside: n/a
Nov 20, 2024
Maintained: Hold
Price Target: n/a
Current: $1.36
Upside: n/a
May 17, 2023
Maintained: Hold
Price Target: n/a
Current: $0.00001
Upside: n/a
Aug 10, 2022
Maintained: Hold
Price Target: n/a
Current: $6.02
Upside: n/a
Jan 13, 2022
Maintained: Hold
Price Target: n/a
Current: $4.53
Upside: n/a
Aug 12, 2021
Maintained: Buy
Price Target: $6
Current: $8.91
Upside: n/a